Evidence map›Paper›PMID 38101397›Full record

ArticleCell metabolism2024

ChREBP is activated by reductive stress and mediates GCKR-associated metabolic traits.

Charandeep Singh, Byungchang Jin, Nirajan Shrestha, Andrew L Markhard, Apekshya Panda, Sarah E Calvo, Amy Deik, Xingxiu Pan, Austin L Zuckerman, Amel Ben Saad and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Changes in the brain [NADFrontiers in aging neuroscience · 2026
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 1 country.

Charandeep SinghLiver Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, MA 02114, USA; Endocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
Byungchang JinLiver Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, MA 02114, USA; Endocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
Nirajan ShresthaLiver Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, MA 02114, USA; Endocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
Andrew L MarkhardHoward Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
Apekshya PandaHoward Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Sarah E CalvoHoward Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Amy DeikBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Xingxiu PanThe Scintillon Institute, San Diego, CA 92121, USA.
Austin L ZuckermanThe Scintillon Institute, San Diego, CA 92121, USA; Program in Mathematics and Science Education, University of California, San Diego, La Jolla, CA 92093; Program in Mathematics and Science Education, San Diego State University, San Diego, CA 92120.
Amel Ben SaadDivision of Gastroenterology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Kathleen E CoreyLiver Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, MA 02114, USA.
Julia SjoquistLiver Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, MA 02114, USA.
Stephanie OsganianLiver Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, MA 02114, USA.
Roya AminiTabriziMetabolomics Platform, Comprehensive Cancer Center, the University of Chicago, Chicago, IL 60637, USA.
Eugene P RheeEndocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA; Nephrology Division, Massachusetts General Hospital, Boston, MA 02114, USA.
Hardik ShahMetabolomics Platform, Comprehensive Cancer Center, the University of Chicago, Chicago, IL 60637, USA.
Olga GoldbergerHoward Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
Alan C MullenDivision of Gastroenterology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Valentin CracanThe Scintillon Institute, San Diego, CA 92121, USA; Department of Chemistry, the Scripps Research Institute, La Jolla, CA 92037, USA.
Clary B ClishBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Vamsi K MoothaHoward Hughes Medical Institute and Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Russell P GoodmanLiver Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, MA 02114, USA; Endocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: rpgoodman@mgh.harvard.edu.
Massachusetts General Hospital · USBroad Institute · USHoward Hughes Medical Institute · USUniversity of Chicago · USUniversity of Massachusetts Chan Medical School · USSan Diego State University · USScintillon Institute · USScripps Research Institute · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
Mitochondrial Parts, Pathways, and PathogenesisR35GM122455 · NIGMS · BROAD INSTITUTE, INC. · PI MOOTHA, VAMSI KRISHNA · 2017 to 2021
$4.0M
Expanding the set of genetically encoded tools for compartment-specific manipulation of redox metabolism in living cellsR35GM142495 · NIGMS · SCINTILLON INSTITUTE FOR PHOTOBIOLOGY · PI Valentin Cracan · 2021 to 2026
$3.2M
An NADH-ChREBP axis in fatty liver disease and dyslipidemiaR01DK134675 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Russell Paul Goodman · 2023 to 2026
$2.0M
A METABOLIC BIOMARKER OF HEPATIC NADH/NAD+ RATIOK08DK115881 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI GOODMAN, RUSSELL PAUL · 2018 to 2022
$865k
Identifying genetic regulators of hepatic reductive stress in diversity outbred miceR03DK131243 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI GOODMAN, RUSSELL PAUL · 2022 to 2023
$260k
Defining and targeting the compartmentalization of redox metabolism in aging using novel genetically encoded toolsR03AG067301 · NIA · SCINTILLON INSTITUTE FOR PHOTOBIOLOGY · PI CRACAN, VALENTIN · 2020 to 2021
$192k
Engineered flavin-dependent enzymes for probing redox environment and regulationK99GM121856 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI CRACAN, VALENTIN · 2017 to 2018
$180k
NIA NIH HHS R03 AG067301NIDDK NIH HHS K08 DK115881NIDDK NIH HHS P30 DK040561NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R01 DK134675NIDDK NIH HHS R03 DK131243NIGMS NIH HHS K99 GM121856NIGMS NIH HHS R35 GM122455NIGMS NIH HHS R35 GM142495Wellcome Trust
6 · The paper itself

Abstract

Common genetic variants in glucokinase regulator (GCKR), which encodes GKRP, a regulator of hepatic glucokinase (GCK), influence multiple metabolic traits in genome-wide association studies (GWASs), making GCKR one of the most pleiotropic GWAS loci in the genome. It is unclear why. Prior work has demonstrated that GCKR influences the hepatic cytosolic NADH/NAD

Indexed as

Genome-Wide Association StudyGlucokinaseAdaptor Proteins, Signal TransducingBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsGlucoseHumansLiverTranscription FactorsAdaptor Proteins, Signal TransducingBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsGCKR protein, humanGlucokinaseGlucoseMLXIPL protein, humanTranscription FactorsChREBPfatty liver diseaseFGF21gastric bypass surgeryGCKGCKRmetabolismMLIXPLNAD(+)NADHreductive stresstrigylcerides

Identifiers

PMID38101397
PMCPMC10842884
OpenAlexW4389744379

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.